Ramiro G Peru insider trades: Elevance Health (ELV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ramiro reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | ELV | ↑ Buy | 1,000 | $366.05 | $366K | Direct | Jul 17, 2026 (0d) |
| May 21, 2026 | SM | ↓ Sell | 24,553 | $33.98 | $834K | Direct | May 22, 2026 (1d) |
| Mar 4, 2025 | SM | ↑ Buy | 5,000 | $28.72 | $144K | Direct | Mar 5, 2025 (1d) |
| Aug 5, 2024 | ELV | ↓ Sell | 753 | $531.52 | $400K | Direct | Aug 6, 2024 (1d) |
| Feb 7, 2024 | ELV | ↓ Sell | 753 | $500.00 | $377K | Direct | Feb 9, 2024 (2d) |
| Aug 29, 2023 | SM | ↓ Sell | 15,670 | $41.14 | $645K | Direct | Aug 31, 2023 (2d) |
| May 19, 2022 | ANTM | ↓ Sell | 990 | $468.88 | $464K | Direct | May 20, 2022 (1d) |
| Mar 8, 2022 | SM | ↓ Sell | 30,000 | $40.60 | $1.2M | Direct | Mar 10, 2022 (2d) |
| May 24, 2021 | ANTM | ↓ Sell | 1,308 | $398.02 | $521K | Direct | May 26, 2021 (2d) |
| Jun 8, 2020 | ANTM | ↓ Sell | 1,102 | $300.00 | $331K | Direct | Jun 10, 2020 (2d) |
| Mar 9, 2020 | SM | ↑ Buy | 22,500 | $2.35 | $53K | Direct | Mar 10, 2020 (1d) |
| Feb 24, 2020 | SM | ↑ Buy | 7,500 | $7.67 | $58K | Direct | Feb 25, 2020 (1d) |
| May 21, 2019 | ANTM | ↓ Sell | 1,656 | $275.00 | $455K | Direct | May 23, 2019 (2d) |
| May 18, 2018 | ANTM | ↓ Sell | 2,248 | $231.57 | $521K | Direct | May 21, 2018 (3d) |
| May 30, 2017 | ANTM | ↓ Sell | 2,681 | $181.58 | $487K | Direct | Jun 1, 2017 (2d) |
| Mar 8, 2017 | SM | ↑ Buy | 1,500 | $23.40 | $35K | Direct | Mar 10, 2017 (2d) |
| Feb 27, 2017 | SM | ↑ Buy | 1,000 | $25.42 | $25K | Direct | Feb 28, 2017 (1d) |
| Jun 29, 2016 | ANTM | ↓ Sell | 3,125 | $130.00 | $406K | Direct | Jul 1, 2016 (2d) |
| Jun 1, 2015 | ANTM | ↓ Sell | 4,709 | $167.91 | $791K | Direct | Jun 2, 2015 (1d) |
| Nov 13, 2014 | SM | ↑ Buy | 5,000 | $51.41 | $257K | Direct | Nov 17, 2014 (4d) |
| Jun 5, 2014 | WLP | ↓ Sell | 5,372 | $108.42 | $582K | Direct | Jun 9, 2014 (4d) |
| May 30, 2013 | WLP | ↓ Sell | 4,656 | $77.90 | $363K | Direct | Jun 3, 2013 (4d) |
| Jun 14, 2012 | WLP | ↓ Sell | 2,946 | $70.00 | $206K | Direct | Jun 15, 2012 (1d) |
| Jun 6, 2011 | WLP | ↓ Sell | 17,537 | $75.64 | $1.3M | Direct | Jun 8, 2011 (2d) |
| Nov 22, 2010 | WLP | ↓ Sell | 3,692 | $60.25 | $222K | Direct | Nov 24, 2010 (2d) |
| Mar 1, 2010 | UNS | ↑ Buy | 1,000 | $29.60 | $30K | Direct | Mar 3, 2010 (2d) |
| Aug 21, 2009 | WLP | ↓ Sell | 19,840 | $54.81 | $1.1M | Direct | Aug 24, 2009 (3d) |
| May 11, 2009 | UNS | ↑ Buy | 1,000 | $26.78 | $27K | Direct | May 12, 2009 (1d) |
| Mar 4, 2009 | UNS | ↑ Buy | 1,000 | $25.27 | $25K | Direct | Mar 5, 2009 (1d) |
| Nov 12, 2008 | UNS | ↑ Buy | 1,000 | $24.76 | $25K | Direct | Nov 13, 2008 (1d) |
| Mar 14, 2008 | WLP | ↑ Buy | 1,000 | $47.21 | $47K | Direct | Mar 17, 2008 (3d) |
| Feb 28, 2007 | PD | ↓ Sell | 30,351 | $125.23 | $3.8M | Direct | Mar 1, 2007 (1d) |
| Mar 8, 2006 | PD | ↓ Sell | 5,666 | $131.56 | $745K | Direct | Mar 10, 2006 (2d) |
| Feb 10, 2006 | WLP | ↓ Sell | 20,000 | $77.51 | $1.6M | Direct | Feb 13, 2006 (3d) |
| Aug 3, 2005 | PD | ↓ Sell | 11,390 | $111.62 | $1.3M | Direct | Aug 4, 2005 (1d) |
| Jul 5, 2005 | PD | ↓ Sell | 11,667 | $93.52 | $1.1M | Direct | Jul 7, 2005 (2d) |
| Jul 5, 2005 | PD | ↓ Sell | 562 | $93.52 | $53K | Direct | Jul 7, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELV insiders
Open-market trades in the last 12 months
About Ramiro G Peru's insider trades
Ramiro G Peru is a director at Elevance Health (ELV). Since Jul 5, 2005, Ramiro has reported 12 open-market purchases worth $1.1M and 25 sales worth $19.7M on SEC Form 4. In the last 12 months: 1 buy ($366K) and 1 sale ($834K).
Their filings also include grants and awards (52 filings), option exercises (9 filings), shares withheld for taxes (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.